Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
CA 2451919 A1 · Owner: Bader, Joel S. · Inventors: Alsobrook, John P. Ii; Bader, Joel S.; Burgess, Catherine E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein is a nucleic acid sequence that encodes a novel polypeptide. Also disclosed is a polypeptide encoded by the nucleic acid sequence and , antibodies, which immunospecifically-bind to the polypeptide as well as , derivatives, variants, mutants or fragments of the aforementioned , polypeptide polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis treatment, and , prevention of disorders involving this novel human nucleic acid and protein. The invention also provides nucleic acids containing single-nucleotide polymorphisms identified for transcribed human sequences as well as methods , of using the nucleic …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 9, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 9, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 9, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.